Samy Kamal Metyas
Samy Kamal Metyas, MD, FACR, FACP
Assistant Clinical Professor of Rheumatology

University of Southern California


July 01-June 03          Los Angeles County / University of Southern California , Fellow Rheumatology   (LAC+USC). Board Certified

June  2001                  Seton Hall University, Trinitas Hospital, New Jersey, Internal Medicine Residency. Board Certified

Oct. 1993

University of Menoufiya School of Medicine, Egypt. M. Sc. (Master’s Degree) in Orthopedic Surgery.

Feb. 1989

University of Menoufiya School of Medicine, Egypt. M .D, final grades “Very Good”. Honor-roll student, one of the top ten, graduated 1989.



Dr Metyas is an Assistant Clinical Professor of Rheumatology at the University of Southern California, He is also past president of Southern California Rheumatology Society; He is Board Certified Internal medicine and Rheumatology.
He is practicing rheumatology in Covina, California since 2003.
Dr Metyas graduated from Menufiya University, Egypt in 1988, then he received Master degree of orthopedic surgery ( Hand Surgery) in Egypt 1993.
He has multiple publications in peer review journals (12 publications) and presented multiple abstracts in American college of rheumatology meeting and European Congress of Rheumatology, (EULAR) (23 Poster presentations) He is Co-Editor-In Chief of Current Rheumatology Reviews Journal. Member of the journal editorial board of International Journal of Medicine and Medical Sciences, and an invited journal reviewer in Journal of Rheumatology and Journal Clinical Rheumatology
He received multiple honorable awards, including nomination for Hospital Hero award, Certificate of Congressional Recognition, California State Senate Certificate of Recognition. County of Los Angeles Commendation Award, and Peer Satisfaction Award.
Dr. Metyas is conducting multiple clinical trials in different aspects of rheumatology including rheumatoid arthritis, lupus, gouty arthritis, low back pain, and osteoarthritis.
Dr. Metyas is a director of fibromyalgia program in Casa Colina Rehabilitation Hospital, including new modality of managing fibromyalgia with pharmacological and non pharmacological therapy.
He is national and international speaker for many pharmaceutical companies. He is conducting multiple grand rounds in the community hospitals, and multiple community lectures for patients, He teaches  rheumatology board review for American College of Physician board review course. 
Dr Metyas assembles” The Metyas Hope Team” as a fundraiser for the Los Angeles Arthritis Walk, which is part of The Southern California Arthritis Foundation.
He was interviewed with CNN charter Communication Headline News ( HLN)
And other local private TV channels.


Research Interest

His research interests includes

  1. fibromyalgia
  2. Lupus
  3. Rheumatoid arthritis
  4. gout.


Professional Activities:

Honors and Awards


Outstanding Service Award From Southern California Rheumatology Society  for serving as a president of the Southern California Rheumatology society from 2012-2014.


2014 Top Doctor Club Member Award From Arthritis Foundation of Greater Los Angeles.  


Nominated for Hospital Hero Award from National Health foundation for
Outstanding  achievements and contribution to the hospital and community.


Certificate Of Appreciation Awarded from Arthritis Foundation to Dr Samy
Metyas in recognition of valuable contributions to Arthritis Townhall 2011.


“Award of Distinction for Leadership” presented by Citrus Valley Health
 Partners: Resource Center for Rheumatic Diseases, July 28, 2007.



  1. Meet our editorial board member. Dr. Samy Metyas MD, MSc, FACR, FACP. Current Rheumatology Reviews,2015, Vol 11, No. 2-69.
  2. Metyas S, Ibrahim M, Solyman J, Yeter KC, Arkfeld DG. Giant cell arteritis with visual loss following zoledronic acid infusion. Int J Rheum Dis. 2014. Jan;17(1):113-5. doi: 10.1111/1756-185X.12263. Epub 2013 Dec 13. PubMed PMID: 24472274.
  3. Samy Metyas, Magdy Tawadros, Karen Yeter, and Daniel Arkfeld ; “ Neurosarcoidosis mimicking multiple sclerosis successfully treated with Methotrexate and Adalimumab” Letter to the editor. International Journal Of Rheumatology 2013 1-3.
  4. Metyas S, Rouman H, Arkfeld, D Pregnancy in a patient with gouty arthritis secondary to pseudo-Bartter syndrome. . J Clin Rheumatol.2010 Aug;16(5):219-20.
  5. H Bassiouni, K Zaki, M Elshorbagi, A Mustapha, R Tantawi, H Ali, S Metyas, DG Arkfeld. Relating bone marrow oedema to hs-CRP in knee osteoarthritis. Indian Journal of Rheumatology 2010 March Volume 5, Number 1; pp. 11–15.
  6. Metyas SK, Tadros RM, Arkfeld DG.  “Adalimumab-Induced Noncaseating Granuloma in the Bone Marrow of a Patient being Treated for Rheumatoid Arthritis.”  Rheumatol Int. 2008  Sep 2.
  7. Metyas S., La D, and Arkfeld DG.  “The Use of the Tumor Necrosis Factor Antagonist Infliximab in Heart Transplant Recipients: Two Case Reports.”  Annals Rheumatic Disease. 2007 Nov; 66(11):1544-5.
  8. Samy K Metyas and Hal M Hoffman : “Maintenance Anakinra Prevents Symptoms of Familial Cold Autoinflammatory Syndrome and Raynaud’s Disease.” Journal of Rheumatology 2006; 33: 2085-7.
  9. Elyse Rubenstein, Danial Arkfeld, Samy Metyas, Shuntaro Shinada, Sonya  Ehresmann and Howard Liebman. “Rituximab Treatment for Resistant Antiphospholipid Syndrome.” J Rheumatol 2006; 33: 355-7.
  10. Lacson S, Metyas S,  and Arkfeld D . “Hip Arthroplasty in a 101-Year-Old Patient.” Journal of Clinical Rheumatology. 11(3): 180, June 2005.   
  11. Stohl W, Metyas S, Tan SM, Cheema GS, Oamar B, Xu D, RoschkeV, Wu Y, Baker KP, and  Hilbert DM. “Inverse Association between Circulating APRIL Levels and Serologic and  Clinical Activities in Patients with Systemic Lupus Erythematosus.” Annals Rheumatic Disease 2004 Sep, 63 (9): 1096-103.
  12. Samy Metyas, Danial Arkfeld, Deborah Forrester, and Glenn Ehresmann. “Infliximab Treatment of  Familial Mediterranean Fever and its Effect on Secondary AA Amyloidosis. Journal of Clinical Rheumatology 10 (3): 134-137 June 2004.
  13. Metyas SK , Lum CA, Raza AS, Vaysburd M, Forrester DM, and Quismorio FPJr. “Inflammatory Arthritis Secondary to Metastatic Gastric Cancer.” J Rheumatol. 2003 Dec; 30 12): 2713-5.
  14. Stohl W, Metyas S, Tan SM, Cheema GS, Oamar B, Xu D, RoschkeV, Wu Y, Baker KP, and Hilbert DM.  “B Lymphocyte Stimulator Overexpression (BLYS) in Patients with Systemic Lupus Erythematosus: Longitudinal Observations.” Arthritis Rheum. 2003 Dec; 48(12): 3475-86.
  15. Metyas SK, Mithani VK, Tempera P. Dieulafoy’s Lesion, “A Rare Cause of Lower Gastrointestinal Hemorrhage.” Hospital Physician. September 2001; (37) 9: 41-45.


clinical-anesthesia Journal Flyer